ClinicalTrials.Veeva

Menu

Effect of Transcutaneous Electroacupuncture on Functional Abdominal Bloating/Distension

X

Xi'an Jiaotong University

Status

Unknown

Conditions

Functional Abdominal Bloating/Distension

Treatments

Device: Transcutaneous Electroacupuncture

Study type

Interventional

Funder types

Other

Identifiers

NCT04916106
S2020-YF-YBSF-0237 (Other Identifier)
2018079

Details and patient eligibility

About

Functional abdominal bloating/distension (FAB/D) is a common functional bowel disorder that lacks effective treatment options. Transcutaneous electroacupuncture (TEA) as a new therapeutic method has great effect on functional gastrointestinal diseases such as functional dyspepsia and functional constipation. Research on TEA for FAB/D has not yet been explored.

Full description

Functional abdominal bloating/distension (FAB/D) is a common functional bowel disorder that lacks effective treatment options. Rome IV was introduced in 2016. Studies have shown that bloating may affect about 30% general population and 96% of patients with functional gastrointestinal disorders (FGID).Transcutaneous electroacupuncture (TEA) as a new therapeutic method has great effect on functional gastrointestinal diseases such as functional dyspepsia and functional constipation. Research on TEA for FAB/D has not yet been explored. Thirty patients who fulfilled the Rome IV diagnostic criteria of FAB/D in the department of the second affiliated hospital of Xi'an jiaotong University.Inclusion criteria included: Symptoms of recurrent abdominal fullness, pressure, or a sensation of trapped gas (bloating), and/or measurable (objective) increase in abdominal girth (distention) more than 6 month;the main symptoms appeared in the past 3 months;Not taking related drugs; aged 18-65 years old;From January 2020 to December 2021; Sign informed consent. All patients were randomly assigned to 3 groups and received TEA at Zusanli (ST36) and Neiguan (PC6) with 3 diffrent parameter for 4weeks. The symptom severity score, abdominal girth, electrogastrogram (ECG) and orocecal transit time (OCTT) ,heart rate variability (HRV) ,rectal sensitivity and intestinal flora were recorded at baseline and after 2-week treatment, respectively. The symptom severity score was repeated at baseline and after 4-week treatment. Through the comparison of the index before and after TEA treatment to identify optimal stimulation parameters and explore its possible mechanism. The study was proved by the medical ethics committee of the Second Affiliated Hospital of Xi'an jiaotong University.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Clinical diagnosis of Functional bloating/distension with Rome IV;
  2. Aged 18-65 years old;

Exclusion criteria

  1. Have taken drugs that may affect gastrointestinal motility in the past week;
  2. Have taken antibiotics and probiotics in the past month;
  3. The history of gastrointestinal surgery;
  4. Helicobacter pylori is not cleared;
  5. Pregnant and breastfeeding women;
  6. Skin allergies.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

60 participants in 3 patient groups

One parameter TEA group for 4 weeks
Experimental group
Description:
Choose two acupoints,give 25Hz electrical stimulation for 4 weeks.
Treatment:
Device: Transcutaneous Electroacupuncture
Another parameter TEA group for 4 weeks
Experimental group
Description:
Choose two acupoints,give 100 Hz electrical stimulation for 4weeks.
Treatment:
Device: Transcutaneous Electroacupuncture
Sham-TEA group for 2 weeks, and the random TEA for the next 2 weeks.
Experimental group
Description:
Choose two non-acupoints,give 25Hz and 100Hz electroacupuncture stimulation respectively for the first 2 weeks. Then give supplement TEA treatment as described above for the next 2 weeks.
Treatment:
Device: Transcutaneous Electroacupuncture

Trial contacts and locations

1

Loading...

Central trial contact

Fei Dai; Yindi Chen

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems